✦ LIBER ✦

A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease

✍ Scribed by Doody, Rachelle S.; Raman, Rema; Farlow, Martin; Iwatsubo, Takeshi; Vellas, Bruno; Joffe, Steven; Kieburtz, Karl; He, Feng; Sun, Xiaoying; Thomas, Ronald G.; Aisen, Paul S.; Siemers, Eric; Sethuraman, Gopalan; Mohs, Richard

Book ID: 120939532
Publisher: Massachusetts Medical Society
Year: 2013
Tongue: English
Weight: 537 KB
Volume: 369
Category: Article
ISSN: 0096-6762
DOI: 10.1056/NEJMoa1210951

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

What Can Be Inferred from the Interrupti

What Can Be Inferred from the Interruption of the Semagacestat Trial for Treatment of Alzheimer's Disease?

✍ Jeffrey Cummings 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Prevalence of asymptomatic vasogenic ede

Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer’s disease study cohorts from phase 3 trials of semagacestat and solanezumab

✍ Christopher Carlson; Wahiba Estergard; Joonmi Oh; Joyce Suhy; Clifford R. Jack J 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 381 KB

Development of semagacestat (LY450139),

Development of semagacestat (LY450139), a functional γ-secretase inhibitor, for the treatment of Alzheimer's disease

✍ Henley, David B; May, Patrick C; Dean, Robert A; Siemers, Eric R 📂 Article 📅 2009 🏛 Informa plc 🌐 English ⚖ 335 KB

Disappointing results for phase III sema

Disappointing results for phase III semagacestat trial

📂 Article 📅 2013 🏛 Adis International Limited (now part of Wolters Kl ⚖ 111 KB

Phase 3 Trials of Solanezumab for Mild-t

Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

✍ Doody, Rachelle S.; Thomas, Ronald G.; Farlow, Martin; Iwatsubo, Takeshi; Vellas 📂 Article 📅 2014 🏛 Massachusetts Medical Society 🌐 English ⚖ 514 KB

Results of a recent treatment trial in A

Results of a recent treatment trial in Alzheimer's disease

✍ Ruth A. Mulnard 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 178 KB